| Literature DB >> 16502428 |
Hayley L Archer1, Julie C Evans, David S Millar, Peter W Thompson, Alison M Kerr, Helen Leonard, John Christodoulou, David Ravine, Lazarus Lazarou, Lucy Grove, Christopher Verity, Sharon D Whatley, Daniela T Pilz, Julian R Sampson, Angus J Clarke.
Abstract
A translocation that disrupted the netrin G1 gene (NTNG1) was recently reported in a patient with the early seizure variant of Rett syndrome (RTT). The netrin G1 protein (NTNG1) has an important role in the developing central nervous system, particularly in axonal guidance, signalling and NMDA receptor function and was a good candidate gene for RTT. We recruited 115 patients with RTT (females: 25 classic and 84 atypical; 6 males) but no mutation in the MECP2 gene. For those 52 patients with epileptic seizure onset in the first 6 months of life, CDKL5 mutations were also excluded. We aimed to determine whether mutations in NTNG1 accounted for a significant subset of patients with RTT, particularly those with the early onset seizure variant and other atypical presentations. We sequenced the nine coding exons of NTNG1 and identified four sequence variants, none of which were likely to be pathogenic. Mutations in the NTNG1 gene appear to be a rare cause of RTT but NTNG1 function demands further investigation in relation to the central nervous system pathophysiology of the disorder. Copyright 2006 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16502428 PMCID: PMC2577736 DOI: 10.1002/ajmg.a.31133
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802